Korean Post-marketing Surveillance for Onglyza®
NCT01575483
·
clinicaltrials.gov ↗
COMPLETED
Status
3433
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
No Intervention (subjects were previously treated with Onglyza®)
Sponsor
AstraZeneca